Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating vs Simultaneous AZT and ddI in AIDS/ARC
NCT00001267Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of didanosine in human immunodeficiency virus infection (HIV), sponsored by National Cancer Institute. Started Oct 1990; status: completed.
02
Drugs
didanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00001267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001267.